← Back to headlines
ImmunityBio Reports Q4 GAAP EPS of -$0.06 and Revenue of $38.2M
ImmunityBio announced its GAAP earnings per share of -$0.06 and reported revenue of $38.2 million for the latest quarter.
23 Feb, 13:06 — 23 Feb, 13:06
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Albanian MP Discusses Rising Prices, Stagnant Incomes, and EU Integration
10m ago
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
18m ago